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hospital to evaluate the long-term outcomes of patients undergoing bifurcation PCI.
Between November 2003 and December 2007, we identified 360 patients who were
treated with either CS (n=304) or CT (n=56). The primary end-point was the occurrence
of MACE defined as the composite of death, myocardial infarction and target vessel
revascularization.
Results: After a median follow-up of 4.1 years (3.0-5.1), the occurrence of MACE
was 24.0% in CS and 23.2% in CT (p=0.46) and the composite of MACE/Angina
class≥2 was 27.3% and 28.6% respectively (p=0.23). Multivariable analysis showed
that creatinine clearance <60 ml/min (odds-ratio[OR]=1.71; p=0.022) and left
ventricular ejection fraction <40% (OR=2.14; p=0.008) were the only independent
predictors of MACE/Angina≥2 while a higher reference diameter of the main vessel
(OR=0.57; p=0.022), a bifurcation angle <50% (OR=0.59; p=0.045) and the
performance of final kissing balloon (OR=0.75; p=0.007) were associated with a
protective effect.
Conclusion: In our series, the crush and culotte techniques were associated with similar
long-term outcomes. Additional factors including bifurcation angle, final kissing
balloon and vessel reference diameter were important variables that impacted patient
outcomes.
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Background: For Medina (0,1,0) and (0,0,1) lesion, stent implantation at ostium of
bifurcation may finish with incomplete coverage of lesion and may cause proximal
edge restenosis. But if we crossover other branch with stent, additional balloon
dilatation for healthy vessels through jailed strut to maintain access route for other
branch with single balloon or kissing balloon technique may be needed. So this study
was aimed to investigate the outcomes of ostial and crossover stent implantation for
Medina (0,1,0) and (0,0,1) bifurcated lesion.
Methods: From April 2007 to December 2009, total 5036 lesions had percutaneous
coronary intervention at our institute. Subject for the study was serial 217 denovo
bifurcated lesions classified for Medina (0,1,0) or (0,0,1) and implanted drug-eluting
stent (sirolimus-, paclitaxel-, zotarolimus-eluting stent). Subject was divided to 2
groups with different stenting techniques, ostial stent group (OS group) 60 lesions and
crossover stent group (CS group) 157 lesions. Primary endpoint was binary restenosis
(defined as %diameter stenosis>50% in QCA at follow up angiogram, mean
307±181days from PCI) and also target lesion revascularization (TLR) rate of each
group was calculated. Variables were compared over 2 groups retrospectively.
Results: Baseline characteristics were similar. Intravascular ultrasounds usage was
62% in OS group and 66% in CS group (p=0.64). In CS group, additional balloon
dilatation for healthy vessels through jailed strut with single balloon 11% and with
kissing balloon technique 45% performed. Binary restenosis rate, TLR rate of OS and
CS group were 10% vs. 11% (p=1.00), 8% vs. 6% (p=0.55), respectively.
Conclusion: Ostial stenting technique for Medina (0,1,0) or (0,0,1) bifurcated lesions
provided similar outcomes to crossover stenting technique which may be acceptable.
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Background: Although general acknowledgment of association between peri-
procedural myocardial infarction (pMI) and subsequent mortality, there has been
controversy about the clinical significance of pMI. We sought to evaluate frequency,
risk factors, and prognostic significance of pMI in patients undergoing percutaneous
coronary intervention (PCI) for bifurcation lesion.
Methods: Consecutive 1668 patients who received non-left main bifurcation lesion
PCI were enrolled. We excluded patients with elevated baseline creatine kinase-
myocardial band (CK-MB). The pMI was defined as peak CK-MB ≥3 times of the
upper limit of normal. Primary endpoint was long-term cardiac mortality.
Results: Among the 1188 patients, pMI occurred in 119 patients (10%). The occurrence
of pMI was significantly related to left ventricular ejection fraction <50% (adjusted
HR: 2.08, 95% CI: 1.13-3.82, p=0.018), multi-vessel coronary artery disease (adjusted
HR: 2.28, 95% CI: 1.36-3.81, p=0.002), and PCI-related acute closure in side branch
(adjusted HR: 3.34, 95% CI: 1.23-9.02, p=0.018). During median follow-up of 23
months, patients with pMI had 3 times more long-term cardiac mortality rate (0.7%
versus 2.5%, p=0.026) and had 5 times long-term definite and/or probable stent
thrombosis rate (0.5% versus 2.5%, p=0.005) in univariate analysis. However, the rate
of MI (0.8% versus 1.1%, p=0.87) and TLR (3.4% versus 5.0%, p=0.56) were similar
between the 2 groups. After multivariate adjustment, the association between pMI and
≤30 day cardiac mortality was significant (adjusted HR: 12.32, 95% CI: 1.07-141.37,
p=0.044), but pMI did not remain as independent prognostic factor of long-term cardiac
mortality (adjusted HR: 2.40, 95% CI: 0.48-11.98, p=0.29).
Conclusion: The occurrence of pMI is associated with adverse baseline clinical,
angiographic, and procedural characteristics. The pMI is significant predictor of ≤30
day, but could not independently predict long-term cardiac mortality in patients with
normal pre-procedural level of CK-MB undergoing bifurcation lesion PCI.
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Background: We studied a new method for detection of ischemia in SB territory after
MV stenting using intracoronary guidewire as an ECG electrode.
Methods: After placement of intracoronary guidewires in MV and SB, the uninsulated
proximal ends of the wires were connected to unipolar V leads. Intracoronary unipolar
ECGs (icECG) were recorded before, during and after stent placement and at the end
of the procedure. The maximal ST-segment elevation during the intervention and 5
min after the procedure was recorded in SB and MB. Finally, the coronary wire was
placed in every distal vessels with a reference caliber >1.5mm, thus “mapping” the
distal zones for the presence and distribution of ischemia. The patient population
consisted of 52 patients with stable/unstable angina. Troponin I levels were obtained
before and after PCI in all Medina types bifurcation stenoses, except for 001. All
patients received main vessel stent/s and neither SB was stented.
Results: From 52 patients, 71% were males, mean age was 67±8, 9 patients (29%)
were diabetics. Thirty seven percent had previous myocardial infarction, 41% previous
PCI, 69% - multivessel disease. The main treated vessel was LAD (75%). The SB had
initially significant (>50% DS) stenosis in 48% of cases (23/48, Medina type xx1).
After PCI, 22 patients had elevated troponin (48%). On icECG the maximal ST-
segment elevation was 13±8 mm in MB and 8±7 mm in SB (p=.034). At the end of the
procedure 29 patients had residual ST elevation (60%): 6 (13%) SB only, 10 (21%)
MB only, 13 (27%) in both branches. Two medium size (1.2-1.5 mm) SBs were
occluded and remained closed, and icECG was not recorded. Compared to those
without enzyme leakage, in troponin (+) after PCI patients, the residual ST-segment
elevation was significantly higher in MB (2.9±3.0mm vs. 0.1±1.9mm, p=.013), in SB
(1.6±2.1mm vs. 0.1±2.4mm, p=.05), as was SB final ostial stenosis (57±27% vs.
34±20%, p=.041). The icECG final STE>3mm had sensitivity of 84%, specificity of
91% to detect periprocedural myonecrosis (troponin I elevation), positive predictive
value of 89% and negative predictive value of 84%. The sensitivity increased to 100%
if postprocedural SB occlusion was added to residual ST-segment elevation.
Conclusion: The intracoronary ECG is a highly sensitive and specific method for
differentiation of the region of ischemia (MV vs. SB) and prediction of periprocedural
myonecrosis.
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Background: It is well known that the peri-procedural myocardial infarction (PPMI)
was assosciated with poor clinical outcome after stent implantation, whereas it is rarely
known in bifurcation lesion. The purpose of this study was to evaluate long-term
clinical outcomes of PPMI after stent implantation for bifurcation.
Methods: We analyzed 1,210 patients enrolled from Coronary Bifurcation Stenting
(COBIS) registry which was retrospective registry of drug-eluting stenting for
bifurcation lesion in 16 centers of Korea. Of them, 243 patients (20.1%) suffered from
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PPMI. PPMI defined as 3-fold increase in CK-MB or troponin-I after procedure and
patients initially diagnosed with MI excluded.
Results: In multivariate analysis, the independent predictors for PPMI after bifurcation
stenting were acute closure in side branch, unstable angina, more than 30mm in total
stent length of parent vessel (PV), left main or 3 vessel disease, and Taxus® in PV
(HR=4.177; 95% CI=1.993-8.756, HR=2.283; 95% CI=1.581-3.297; HR=1.035; 95%
CI=1.014-1.057, HR=1.759; 95% CI=1.220-2.535 and HR=1.717; 95% CI=1.194-
2.468 respectively). During 22-month follow-up, there was no difference in mortality
between PPMI and no PPMI group (96.3% vs. 98.7%, p=0.168). Propensity score-
adjusted Cox regression analysis showed that the PPMI was not an independent
predictor of mortality (adjusted HR 0.749; 95% CI 0.166 – 3.648, p=0.777).
Kaplan-Meier curves for long-term mortality among no PPMI group, those with CK-
MB or Tn-I increase 3 to 10 times, and with CK-MB or Tn-I increase ≥10 times
Conclusion: In the bifurcation stenting, although PPMI is still occurred frequently,
however, it isn’t significantly associated with long-term mortality.
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Background: The provisional approach has become the default strategy in bifurcation
PCI. However, there are some inherent limitations of the provisional approach
including the acceptance of a suboptimal result at the side branch (SB) and the risk of
SB compromise or even occlusion. A dedicated SB stent may overcome some of these
limitations of provisional stenting by facilitating the procedure. However, there are
limited data to support this approach
Methods: We performed a retrospective cross-sectional survey of the current practice
of provsional stenting for the bifurcation. The survey collected procedural data of 110
bifurcations most recently treated with a provsional approach in 4 centres. We then
compared these data with patients enrolled in the multi-centre European registry of
true bifurcations treated with Sideguard (Cappella Inc., Galway, Ireland) dedicated
side branch stent. The primary endpoint of the study was SB failure defined as: residual
SB stenosis≥50%; inability to re-access the SB after main branch (MB) treatment;
dissection of the SB; and need for cross-over to SB stenting.
Results: Almost all lesions treated were true bifurcations in both the provisional and
Sideguard groups (97% vs. 96%). Procedural success was high in both groups (97%
vs. 96%). In the provisional group, the SB was stented in 15% of cases and 22% had
a SB residual stenosis≥50% at the end of the procedure. The primary endpoint of SB
failure occurred significantly more frequently in the provisional group (33% vs. 5%;
p=0.01). Procedural (78±23 vs. 67±29 mins; p=NS) and flouroscopy time (21.2±8.9
vs. 22+/-5.5; p=NS) were similar in both groups.
Conclusion: SB ostial protection with the Sideguard device reduces SB failure in
comparison to provisional stenting without increasing procedural time. The Sideguard
dedicated bifurcation stent could facilitate bifurcation PCI and make the procedure
more predictable and safe. This approach requires further evaluation in a randomized
controlled trial.
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Background: Provisional stenting is now the default approach for treatment of
bifurcation lesions. It is however still controversial whether dilatation of the Side
Branch (SB) after Main Vessel (MV) stenting is beneficial and when Kissing Balloon
(KB) inflation should be performed.
Methods: Optimisation using final KB technique was compared with a simpler
sequential 2 step SB-MV dilatation without kiss in a series of drug eluting stents (n=26)
delivered in a bench model of a representative coronary bifurcation. Stent apposition
and stent area was quantified at different locations along the MV from micro-CT scans.
Vessel wall stresses and detailed reconstruction of blood flow patterns were obtained
in the model using Finite Element Analysis (FEA) and Computational Fluid Dynamics
(CFD).
Results: SB ostial stenosis was on average 20.9 ± 8.7 % after KB and 25.6 ± 11.6 %
after 2-Step sequential optimization (p=0.25, ns) compared to 69.2 ± 7.8 % without
SB dilatation, p<0.0001. Differences were observed between the stent platforms with
CoCr and PtCr stents producing higher ostial stenosis than SS based platforms
(respectively 27.3 ± 8.5% and 20.0 ± 10.2%, p=0.06). KB induced a significant
asymmetric expansion of the lumen proximal to the SB and led to a higher risk of
incomplete stent apposition at the proximal stent edge (36.4 ± 29.8 % vs. 3.8 ± 10.1 %
for 2-step, p=0.0016). SB dilatation alone without further MV post-dilatation is
associated distortion of the stent at the MV ostium, resulting in a high risk of stent
malapposition opposite the SB. Rate of malapposition in the bifurcation after KB and
2-Step was respectively 22.1 ± 8.9 % and 26.6 ± 8.9 %, a significant reduction
compared to SB dilatation (55.3 ± 16.8 %, p<0.0001) or MV stenting only (47.0 ± 8.5
%, p<0.0005).
Conclusion: Sequential 2-step post-dilatation of the SB and MV may be a suitable
alternative to final Kissing Balloon Inflation after provisional stenting of bifurcations.
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Background: Treatment of coronary bifurcation lesion by drug eluting stent (DES)
reduced the restenosis and major adverse cardiac events compared to by bare metal
stent (BMS). Several study evaluated the tissue formation on the jailed strut at follow-
up term post-DES implant by OCT. The serial change of jailed struts at long-term after
implantation has not been clarified. The aim of this study was to evaluate serial change
of tissue formation at bifurcation lesions.
Methods: 20 true coronary bifurcation lesions treated with sirolimus eluting stent
(SES) were analyzed by serial optical coherence tomography (OCT) follow-up at 6
month and very late phase (43 to 73 months). We evaluated stent apposition and
coverage of neointimal tissue on the strut. Thickness of neointima were measured for
apposed strut, jailed strut and thickness of tissue surrounding jailed strut. The change
of thrombus formation was also assessed.
Results: Neointimal thickness of non-jailed (well-apposed) strut increased from 6-
month to very late phase, and on jailed strut, both neointimal tissue thickness
(67.0±49.2 to 114.0±64.9μm, P<0.05) and whole tissue thickness (332.0±165.8 to
430.7±138.3μm, P<0.05) increased. %uncovered strut at bifurcation lesion were
decreased (7.5±7.7% to 4.1±5.6%, P<0.05). The frequency of thrombus on jailed struts
at 6 months were 40% (8/20) lesions, which disappeared at very late phase.
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